Social•Jun 4, 2026
Dimension VC Ups Fund Target to $750M for AI‑biotech
Back in March, I first reported that Dimension was looking to raise ~ $700 million fund. The VC firm, which has nestled itself at the buzzy intersection of AI and biotech, confirmed that in an SEC filing today, bumping up the amount to $750 million. https://t.co/GKQxYCodXJ
By Allison DeAngelis
Social•Feb 25, 2026
FDA Rejects Experimental Rare Blood Cancer Therapy
An experimental therapy for a rare blood cancer was on the path toward approval by the Food and Drug Administration last year — with internal reviewers recommending it be cleared — before the agency rejected the drug last month, @adamfeuerstein...
By Allison DeAngelis